Lyon, June 2, 2022 – 6 p.m. CEST – SMAIO (Software, Machines and Adaptive Implants in Orthopedics – Euronext Growth Paris ISIN Code: FR0014005I80 / Mnemonic: ALSMA, eligible PEA-PME), a French player specializing in complex spinal surgery with , a global offering consisting of software, implantable devices and related services, today announced that it has obtained 510(k) registration from the Food and Drug Administration (FDA) for its Balance Analyzer 3D surgical planning software.
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected]